Close

Analyst Ratings for Acer Therapeutics (ACER) [Buys]

ACER Rating Summary

ACER Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ACER
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $1.50 (+66.7%) * Over Last 12-Mos
Rating Score: 2.9 / 10   Percentile Rank: 24%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/23/2019 Wedbush
» Updated 6/25/2019
Laura Chico New Coverage Outperform
(N/A)
8.00
(48.00)
19.71
(0.90)
-95.43% Details
12/7/2017 Brookline Capital Markets
» Updated 8/15/2018
Kumaraguru Raja New Coverage Buy
(N/A)
51.00
(N/A)
14.81
(0.90)
-93.92% Details
Like ACER Ratings? Also take a look at SUM, ZVRA, NXGN

ACER Ratings News